Staph infections are posing a deadly new threat in the form of MRSA pneumonia. MRSA may be behind 4 out of 5 the staph pneumonia cases that doctors see.
With some infections killing within 4 days some patients are not being fully diagnosed and treated. In some cases – about a third - the MRSA pneumonia follows a bout of influenza. Staph is a challenge to anyone suffering from influenza, but the stakes are raised considerably in populations where the drug resistant varieties of MRSA are being carried by in excess of 10% of children and young people. The staph pneumonia patients’ average age is often around 16.
Those recovering from a recent flu are about twice as likely to die. Staph is capable of reaching the lungs, often after colonising the nose. The flu virus shuts down the normal defences of the lung and the staph bacteria then flourishes.
Failure rates of 40% have been reported for vancomycin, the drug of choice for difficult cases of MRSA. With new strains of MRSA needing bigger doses and poor penetration into epithelial cell lining fluid by the drug some are looking to the more expensive Linezolid. (Zyvox) for MRSA pneumonia cases. Trials have produced mixed results but some studies indicate Linezolid is more effective.
Your MRSA Questions Answered
How do you catch MRSA
MRSA Skin Infections
Is MRSA Contagious?
Where could you catch MRSA?
Is there an MRSA Incubation period
Chronic MRSA Infections & MRSA Reinfection
Are you an MRSA Carrier?
MRSA Colonization - Infected but not sick?
MRSA & Sex - The Facts
MRSA precautions you can take
What is community MRSA
How is MRSA treated
4 Key MRSA Treatments
MRSA Treatment - A short guide
Can you die from MRSA?
MRSA treatment - Official USA guidelines
MRSA Pneumonia & Flu
MRSA Virus or MRSA Bacteria
What is Mersa